The Preclinical Signal in Routine Abdominal CT: How Mayo's REDMOD and the Pre-Diagnostic Pancreas Force a Rethink of Cancer Screening Math, Workflow Economics, and the Multimodal Future of Risk Inference

Thoughts on Healthcare Markets & Technology Podcast

The Preclinical Signal in Routine Abdominal CT: How Mayo's REDMOD and the Pre-Diagnostic Pancreas Force a Rethink of Cancer Screening Math, Workflow Economics, and the Multimodal Future of Risk Inference — Part II

0:00

-9:50

Paid episode

The full episode is only available to paid subscribers of Thoughts on Healthcare Markets & Technology

The Preclinical Signal in Routine Abdominal CT: How Mayo's REDMOD and the Pre-Diagnostic Pancreas Force a Rethink of Cancer Screening Math, Workflow Economics, and the Multimodal Future of Risk Inference — Part II

Pancreatic cancer leaves detectable morphological signals in routine CT scans up to 18 months before diagnosis — and that changes the screening economics entirely.

May 04, 2026

∙ Paid

Mayo Clinic's REDMOD study demonstrates that pancreatic cancer leaves detectable morphological signals in routine abdominal CT scans obtained for unrelated indications up to 18 months before a formal diagnosis. This episode examines what that finding means for cancer screening economics, workflow design, and the multimodal future of risk inference.

Part …

Continue reading this post for free, courtesy of Thoughts on Healthcare.

Or purchase a paid subscription.